February 12, 2026
The automation-compatible, bead-based method optimizes cfDNA recovery from plasma, serum, urine and cerebrospinal fluid IPSWICH, Mass. -- New England Biolabs (NEB®) announces the release of the Monarch Mag Cell-free DNA (cfDNA) Extraction Kit, which enables consistent, scalable extraction of low-abundance, circulating cell-free DNA (cfDNA) for downstream applications including biomarker discovery and diagnostics development. The magnetic, bead-based workflow is [...]
HighRes® and NVIDIA Partner to Advance AI-Driven Autonomous Laboratories
February 12, 2026
Beverly, MA — HighRes® today announced an expanding collaboration with NVIDIA focused on applying AI to make laboratory automation more reliable, adaptive, and accessible, paving the way toward fully autonomous laboratories. HighRes and NVIDIA share a vision that AI is the key to unlocking the next generation of lab automation, where systems are no longer [...]
February 12, 2026
BOTHELL, Wash. — BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of bioproduction tools and services for the cell and gene therapy (CGT) market, announces it has entered into a multi-year supply agreement with Qkine Limited under which BioLife will distribute certain ctokine and growth factor products manufactured by Qkine for use in cell and [...]
JULABO USA App First to Integrate LiDAR Technology Ensuring Safe Refrigerant Use in Labs
February 12, 2026
Updated app includes personalized product recommendations for enhanced safety compliance ALLENTOWN, Pa. -- JULABO USA announces an update today to its smartphone application, integrating advanced LiDAR technology. This enhancement is designed to assist laboratories in accurately assessing their space for the safe deployment of liquid temperature control units, particularly as the industry transitions to natural refrigerants. This [...]
PacBio Joins iHope Initiative as First Long-Read Genomic Sequencing Partner
February 12, 2026
Integration of HiFi Long-Read Whole-Genome Sequencing Expands the Collective Capabilities of iHope’s Global Rare Disease Network MENLO PARK, Calif. -- PacBio (NASDAQ: PACB), a leading provider of high-quality, long-read sequencing technologies, today announced a collaboration with iHope, a global rare disease genomics program of Genetic Alliance, to integrate PacBio’s HiFi® long-read whole-genome sequencing into iHope’s [...]
Stellaromics Appoints Industry Veterans Stacie Weninger and Steve McPhail to Board of Directors
February 12, 2026
Appointments to bolster rapid scaling and execution of Pyxa™ spatial platform BOSTON -- Stellaromics, a pioneer in high-resolution 3D spatial multi-omics, today announced the appointment of Stacie Weninger, PhD, and Steve McPhail to its Board of Directors. These strategic appointments come at a pivotal time for the company as it scales its innovative Pyxa™ technology and [...]
Bio-Techne Announces Changes to its Leadership Team
February 11, 2026
Dr. Matt McManus to transition from his role as President, Diagnostics and Spatial Biology Segment, effective March 1, 2026 Steve Crouse, Senior Vice President of Bio-Techne's Analytical Solutions Division, has been appointed President, Diagnostics and Spatial Biology Segment, effective March 1, 2026 MINNEAPOLIS -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Dr. Matt McManus, President [...]
Change on Endress+Hauser Supervisory Board
February 11, 2026
Steven Endress to succeed Matthias Altendorf as Supervisory Board President The Endress+Hauser Group’s generational handover continues. The Swiss measurement and automation technology specialist has already announced a sweeping refresh of the Executive Board made necessary by the planned retirement of several long-serving members. Now the time is nearing for a change at the helm of [...]
InSphero and PharmaNest Form a Partnership to Advance Translational Fibrosis Research
February 11, 2026
Schlieren, Switzerland -- InSphero AG, the global market leader in 3D cell-based assays and organ-on-chip systems signed a partnership with PharmaNest Inc, a Princeton, NJ-based digital pathology company. This partnership uniquely positions InSphero’s in the space of the translational application of machine learning tools in combination with human pre-clinical models to decipher complex pathological phenotypes for the identification of effective therapies. A key challenge of these current unmet clinical needs is the prediction of the drug efficacy of complex fibrotic phenotypes in clinical stages. The [...]
HORIBA to Build a New Global Headquarters
February 11, 2026
Advancing global operations and realigning domestic sites to strengthen the organization and lay the groundwork to become a company with annual revenue of 1 trillion yen. HORIBA, Ltd. (President: Masayuki Adachi) announces plans to build a new global headquarters on the site of its current head office in Kisshoin, Minami-ku, Kyoto. Construction began in December [...]

